Search for:

Home
About
Where we work
News
Strategies
Resources

6 March 2020

Gilead launches a phase III trial of remdesivir in people with severe COVID-19. Source

Return to the timeline

Keep in Touch

Our email newsletter has latest news on developments and campaign actions

Subscribe to our mailing list

Twitter

RT @Winnie_Byanyima: What a privilege to visit the Afrigen mRNA vaccine hub in Cape Town! So inspiring to see Africa tackling head-on the i…
yesterday

Make Medicines Affordable Twitter

Instagram

This error message is only visible to WordPress admins

Error: No connected account.

Please go to the Instagram Feed settings page to connect an account.

Make Medicines Affordable Instagram

Facebook

In November 2021, we worked with Matahari Global to map data on #COVID19 tools in 8 countries. Countries examined did not have formal registries for community health workers, nor were they salaried, boding poorly for future pandemic response. We also found that there is a lack of consolidated data on oxygen needs, which will hamper the effectiveness of multilateral oxygen support in 2022. Every Breath Counts says that the broken o2 plants that they know of are ‘the tip of the iceberg’. Countries also reported that stocks of syringes for routine immunisation were being used up for COVID-19 vaccines, and that these stocks were not being replenished quickly enough. View the full report here: itpcglobal.org/blog/resource/data-gaps-in-the-covid-19-response-findings-from-a-mapping-exercise-... ... See MoreSee Less

Data Gaps in the COVID-19 Response: Findings from a mapping exercise on access to COVID-19 technologies

itpcglobal.org

6 days ago ·

ITPC global Facebook

© Copyright ITPC 2022 Cookies Media enquiries Contact us Website by Maraid Design